← Open Payments lookup

CAMILO SERRANO: Open Payments

NPI 1780744250 · CARNEYS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,674 in 118 payments from 15 companies in 2025. Trend: 2023 $1,394 · 2024 $1,556 · 2025 $1,674

Food & beverage: $1,674
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$304
ABBVIE INC.27$247
Teva Pharmaceuticals USA, Inc.16$197
Otsuka America Pharmaceutical, Inc.12$195
E.R. Squibb & Sons, L.L.C.11$160
Janssen Pharmaceuticals, Inc5$120
Axsome Therapeutics, Inc.6$103
Alkermes, Inc.5$91
Vanda Pharmaceuticals Inc.4$75
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$73

Products named: INGREZZA, VRAYLAR, REXULTI, COBENFY, UZEDY, Auvelity, ARISTADA, AUSTEDO XR.

Industry payments across NJ — which companies pay providers there.